Analyzing insurance claims for BlueCross BlueShield of Texas, the authors found that level I and II trauma center expansion was not associated with increased prices or use of trauma activation fees in the state of Texas. Read the article in JAMA.
Vaccines and other biomedical advances will not be sufficient to halt COVID-19, unless we simultaneously counter anti-science aggression, writes Peter Hotez, fellow in disease and poverty, in a new article for PLOS Biology.
The results of this study suggest that Medicare Data on Provider Practice and Specialty, which costs less to obtain than from a for-profit data source, can be used to reliably track the cost and quality effects of vertical integration between hospitals and physicians.
When physicians integrate with hospitals, the cost of health care rises even though there’s no evidence patients get better treatment, the authors write. Journal of General Internal Medicine: https://bit.ly/2lxd4RY
Global deworming programs for children were once believed to improve a child’s chances for health, growth and success in school. New research that claims to debunk the merit of such programs has set off so-called “worm wars” between investigators. The authors aim to resolve the issue through an extended comparison of findings from key economics and epidemiological studies.
Farhan Majid, Su Jin Kang, Peter J. HotezMarch 7, 2019
New research finds that health care consolidation and the integration of hospital and doctor services not only fail to improve quality but also reduce patient satisfaction.
The authors discuss Pakistan’s challenges with neglected tropical diseases (NTDs) and their impact on poverty, child development and overall health in the country.
Alexander J. Blum, Farhan Majid, Peter J. HotezOctober 18, 2018